Driver Bioengineering, Inc. — Form D/A
Driver Bioengineering, Inc. of San Francisco, CA, a company, filed a Form D amendment with the SEC on 2022-02-09. The offering totals $23.6M, of which $23.2M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-02-09
- Form: D/A
- Accession: 0001778974-22-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $23.6M
- Amount sold: $23.2M
- Remaining: $403K
- Investors: 65
- Date of first sale: 2019-05-28
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-341581
Issuer
- Name: Driver Bioengineering, Inc.
- CIK: 0001778974
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 329 Oyster Point Blvd, San Francisco, CA, 94080
- Phone: 310-430-9893
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Scott Dylla | Director | San Francisco, CA |
| Benjamin Wang | Director | San Francisco, CA |
| Gusti Zeiner | Director | San Francisco, CA |
| Wladimir Hogenhuis | Executive Officer | San Francisco, CA |
| Benjamin Wang | Executive Officer | San Francisco, CA |
Other filings by this issuer (1)
More